China Sxt Pharmaceuticals (SXTC) said Monday that it has regained compliance with Nasdaq's minimum bid price listing requirement.
The pharmaceutical company said it regained compliance as its stock price was at least $1 a share for 10 consecutive business days ending March 12.
Shares were up 1.8% in early trading.